In Other News

• Qiagen Agrees to Go Private Through EQT-Led Acquisition

• Point-of-Care Blood Biomarker Test Detects Brain Injury Missed by CT

• Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

• AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer

• Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use

• Hologic and Inpeco Partner to Advance Molecular Laboratory Automation in Europe

• Daily Blood Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

• AI Tool Predicts Immunotherapy Response Using Tumor Senescence Signals

• Single-Cell Profiling Reveals Chemotherapy Resistance Signals in Ovarian Cancer

• Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

• Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

• Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

• AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

• New Variant Tracking Option Expands Molecular Residual Disease Monitoring

• AI Pre-Screening Helps Identify Lung Cancer Cases for Additional Biomarker Testing

• Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

• Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

• New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

• Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

• Multimodal Platform to Combine Blood and Imaging Biomarkers for Lung Nodule Assessment

• AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

• GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

• New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows